Abstract
This was a longitudinal observational cohort study to investigate the association of stunting at 24 months of age and attained adult height. A cohort of 104 Peruvian males (n=47) and females (n=57) was studied from 24 months to after puberty in a rural community in the Peruvian Amazon located 15 km southeast from the urban center of Iquitos. Anthropometric measures were made at 24 months and after puberty. Height for Age Z (HAZ) Scores were calculated and compared to assess the association of HAZ score at 24 months and adult height. 67.7% of males and 54.1% of females who were stunted at 24 m (HAZ<-2.0) recovered (HAZ>-2.0) after puberty, whereas 6.25% of males and 6.06% of females who were not stunted at 24 m (HAZ>-2.0) became stunted (HAZ<-2.0) after puberty. The first 1000 days are not the only critical window for growth promotion. Global and national initiatives to reduce stunting should not exclusively focus on the first two years of life, but also work to promote the nutritional initiatives to promote optimal nutrition and growth throughout childhood and adolescence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NIH grant K01-TW05717, the Bill and Melinda Gates Foundation OPP1066146, and from the Sherrilyn and Ken Fischer Center for Environmental Infectious Diseases at the Johns Hopkins School of Medicine to MK. The Parker Huang Undergraduate Travel Fellowship from Yale University, which funded JS while working on this project and the Leitman Award from the Johns Hopkins Center for Global Health (RK).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was reviewed and approved by the Institutional Review Board of the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD) and the Ethics Committee of Asociacion Benefica PRISMA (Lima, Peru).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available from the corresponding author upon request.
